Cargando…
Animal Models of CMT2A: State-of-art and Therapeutic Implications
Charcot–Marie–Tooth disease type 2A (CMT2A), arising from mitofusin 2 (MFN2) gene mutations, is the most common inherited axonal neuropathy affecting motor and sensory neurons. The cellular and molecular mechanisms by which MFN2 mutations determine neuronal degeneration are largely unclear. No effec...
Autores principales: | De Gioia, Roberta, Citterio, Gaia, Abati, Elena, Nizzardo, Monica, Bresolin, Nereo, Comi, Giacomo Pietro, Corti, Stefania, Rizzo, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541381/ https://www.ncbi.nlm.nih.gov/pubmed/32856204 http://dx.doi.org/10.1007/s12035-020-02081-3 |
Ejemplares similares
-
Neural Stem Cell Transplantation for Neurodegenerative Diseases
por: De Gioia, Roberta, et al.
Publicado: (2020) -
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
por: Costamagna, Gianluca, et al.
Publicado: (2020) -
Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019) -
iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
por: Simone, Chiara, et al.
Publicado: (2014) -
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014)